A multicenter analysis of melanoma recurrence following adjuvant anti-PD1 therapy.

Carina N. Owen,James Larkin,Alexander N. Shoushtari,Matteo S. Carlino,Christian U. Blank,Belinda Lee,Joanna Mangana,Victoria Atkinson,Michael Millward,Farzana Zaman,Arissa Young,Muhammad A. Khattak,Sapna Pradyuman Patel,Christoph Hoeller,Peter Hersey,Dharmisha Chauhan,D Palmieri,Serigne Lo,Alexander M. Menzies,Georgina V. Long

A multicenter analysis of melanoma recurrence following adjuvant anti-PD1 therapy.

2019

9502Background: Adjuvant anti-PD1 monoclonal antibodies (mAbs) prolong recurrence-free survival in high-risk resected melanoma, however patients (pts) recur during or after therapy. The patterns of...

Keywords:

Adjuvant
Melanoma
Pathology
Oncology
Internal medicine
Medicine
anti pd1
Monoclonal antibody

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations